BiochemistrybioRxivPreprint
An inhibitor targeting glycosome membrane biogenesis kills Leishmania parasites
Shih–En Chou, Vishal C. Kalel, Ralf Erdmann
This study identifies an FDA-approved inhibitor that targets glycosome membrane biogenesis in Leishmania parasites, effectively killing them including amastigote forms.